Quantitative Analysis of PiB-PET with FreeSurfer ROIs
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
In vivo quantification of β-amyloid deposition using positron emission tomography is emerging as an important procedure for the early diagnosis of the Alzheimer's disease and is likely to play an important role in upcoming clinical trials of disease modifying agents. However, many groups use manually defined regions, which are non-standard across imaging centers. Analyses often are limited to a handful of regions because of the labor-intensive nature of manual region drawing. In this study, we developed an automatic image quantification protocol based on FreeSurfer, an automated whole brain segmentation tool, for quantitative analysis of amyloid images. Standard manual tracing and FreeSurfer-based analyses were performed in 77 participants including 67 cognitively normal individuals and 10 individuals with early Alzheimer's disease. The manual and FreeSurfer approaches yielded nearly identical estimates of amyloid burden (intraclass correlation = 0.98) as assessed by the mean cortical binding potential. An MRI test-retest study demonstrated excellent reliability of FreeSurfer based regional amyloid burden measurements. The FreeSurfer-based analysis also revealed that the majority of cerebral cortical regions accumulate amyloid in parallel, with slope of accumulation being the primary difference between regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Scatter plot of MCBP values obtained using manually and FreeSurfer defined ROIs (previously shown in [47]).](https://figures.cochat.ai/paper-figures/5bc1a0b97b95410e94f67a6bfcea602d/quantitative-analysis-of-pib-pet-with-freesurfer-rois-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PET imaging analyses were performed using the PET unified pipeline 42,43 (PUP, https://github.com/ysu001/PUP) via XNAT on Dell PowerEdge 1950 servers with Intel Xeon processors running CentOS 5.5 Linux.”
From OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease (2019) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Quality control reviewed post-processing PUP output 42,43 , which includes uptake measure for FreeSurfer-based regions, was included for 1356 PET sessions.”
From OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324 · cited 1×
“FreeSurfer automatically segments and parcellates T1-weighted brain MRIs [26,27,28].”
BackgroundThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationFischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · cited 2×
“Individuals with AD and mild cognitive impairment have been shown to have elevated PiB retention in the cerebral cortex [7,8,9] although elevated PiB retention is also observed in some cognitively normal individuals.”
BackgroundAutomatically Parcellating the Human Cerebral Cortex
Fischl, B. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhg087 · Cited by 4,253 · cited 2×
“Although some degree of variability exists in the automated segmentation procedure [26,28,52], and manual correction of FreeSurferderived boundaries is sometimes necessary, especially in the presence of atrophy, our MRI test-retest study demonstrated excellent reliability of the FreeSurfer based estimation of regional…”
BackgroundMethodDistributed and overlapping representations of faces and objects in ventral temporal cortex
Haxby, J. V., Gobbini, M. I., Furey, M. L., Ishai, A., Schouten, J. L., & Pietrini, P. (2001) · Science · doi:10.1126/science.1063736 · Cited by 3,940 · cited 1×
“The logic here is reminiscent of the demonstration by Haxby and colleagues that classification can be based on less robust features of imaging data [49], Thus, it is not critical to identify the ‘‘optimal’’ set of regions for determination of PiB status.”
BackgroundForecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370 · cited 1×
“The prevalence of Alzheimer’s disease (AD) is expected to increase dramatically worldwide within the next 50 years [1].”
BackgroundEvaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration
Klein, A., Andersson, J., Ardekani, B. A., Ashburner, J., Avants, B., Chiang, M.-C., Christensen, G. E., Collins, D. L., Gee, J., Hellier, P., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.037 · Cited by 2,227 · cited 1×
“Although some degree of variability exists in the automated segmentation procedure [26,28,52], and manual correction of FreeSurferderived boundaries is sometimes necessary, especially in the presence of atrophy, our MRI test-retest study demonstrated excellent reliability of the FreeSurfer based estimation of regional…”
MethodDistribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514 · cited 1×
“Regional binding potentials (BPND) were estimated using Logan graphical analysis [12] with cerebellar cortex as reference [42].”
MethodLogan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479 · cited 2×
“Binding potentials (BPND) are calculated using Logan graphical analysis [12] with cerebellar cortex as the reference region [4,11,13].”
MethodAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Self-citationSheline, Y. I., Price, J. L., Yan, Z., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000446107 · Cited by 1,196 · cited 2×
“18 as the criterion for PiB status determination [11,44,45].”
BackgroundMethodSelf-citationImaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099 · cited 2×
“many amyloid imaging studies using either hand drawn regions [11,13,14,15,17,19] or automatic templates [22,23,24], the rationale for ROI selection typically has been based on which regions have been previously reported as selectively affected by AD [11,16,24].”
BackgroundFrequent amyloid deposition without significant cognitive impairment among the elderly
Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., Ziolko, S. K., James, J. A., Snitz, B. E., Houck, P. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1509 · Cited by 1,059 · cited 4×
“Regional specificity of PiB binding Traditionally, PiB status has been determined by evaluating MCBP, computed by averaging BPND over a fixed set of ROIs [11,14,48].”
BackgroundMethodInfluential[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036 · cited 9×
“The average of BPND from four regions (PREF, PREC, GR, and TEMP) determined the mean cortical binding potential (MCBP) [11].”
BackgroundMethodInfluentialSelf-citationSynthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
Mathis, C. A., Wang, Y., Holt, D. P., Huang, G.-F., Debnath, M. L., & Klunk, W. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030026b · Cited by 979 · cited 1×
“Preparation of PiB was carried out according to the published protocol [37].”
MethodJack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958 · cited 1×
“Regional specificity of PiB binding Traditionally, PiB status has been determined by evaluating MCBP, computed by averaging BPND over a fixed set of ROIs [11,14,48].”
MethodAPOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830 · cited 2×
“Binding potentials (BPND) are calculated using Logan graphical analysis [12] with cerebellar cortex as the reference region [4,11,13].”
BackgroundMethodSelf-citationReiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785
Amyloid deposition, hypometabolism, and longitudinal cognitive decline
Landau, S. M., Mintun, M. A., Joshi, A. D., Koeppe, R. A., Petersen, R. C., Aisen, P. S., Weiner, M. W., Jagust, W. J., & Initiative, F. T. A. D. N. (2012) · Annals of Neurology · doi:10.1002/ana.23650 · Cited by 727 · cited 1×
“Since the start of this work, a few groups has published their research using FreeSurfer to facilitate PiB imaging quantification [32,33,34], the relationship of FreeSurfer based quantification to manual based quantification has not been examined.”
BackgroundSelf-citationKinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
Price, J. C., Klunk, W. E., Lopresti, B. J., Lu, X., Hoge, J. A., Ziolko, S. K., Holt, D. P., Meltzer, C. C., DeKosky, S. T., & Mathis, C. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600146 · Cited by 720 · cited 3×
“many amyloid imaging studies using either hand drawn regions [11,13,14,15,17,19] or automatic templates [22,23,24], the rationale for ROI selection typically has been based on which regions have been previously reported as selectively affected by AD [11,16,24].”
BackgroundMethodClinical Dementia Rating (CDR)
(2001) · Management of Dementia · doi:10.3109/9780203213896-34 · Cited by 696
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., Koeppe, R. A., Mathis, C. A., Weiner, M. W., Jagust, W. J., et al. (2009) · Brain · doi:10.1093/brain/awn320 · Cited by 684
Lopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., MELTZER, C. C., Schimmel, K., Tsopelas, N. D., DeKosky, S. T., et al. (2005) · PubMed · Cited by 601
Jovicich, J., Czanner, S., Han, X., Salat, D., van der Kouwe, A., Quinn, B., Pacheco, J., Albert, M., Killiany, R., & Blacker, D. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.02.010 · Cited by 559 · cited 1×
“In addition, since FreeSurfer is widely used in AD research [29,30,51], a FreeSurferbased amyloid imaging analysis protocol would allow integration of amyloid deposition measurements with cortical thickness, volume and other anatomical measurements.”
MethodMorris, J. C., & Price, J. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:101 · Cited by 513 · cited 1×
“The future success of disease-modifying therapies will depend on accurate early diagnosis before the onset of clinical symptoms [2,3,4].”
BackgroundSelf-citationMorris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.269 · Cited by 476 · cited 2×
“Ab deposition in asymptomatic individuals may represent a preclinical biomarker of AD [10,11].”
BackgroundMethodSelf-citationLandau, S. M., Breault, C., Joshi, A. D., Pontecorvo, M., Mathis, C. A., Jagust, W. J., & Mintun, M. A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109009 · Cited by 462 · cited 1×
“Since the start of this work, a few groups has published their research using FreeSurfer to facilitate PiB imaging quantification [32,33,34], the relationship of FreeSurfer based quantification to manual based quantification has not been examined.”
Self-citationMarcus, D. S., Olsen, T. R., Ramaratnam, M., & Buckner, R. L. (2007) · Neuroinformatics · doi:10.1385/ni:5:1:11 · Cited by 459
Self-citationThe use of PET in Alzheimer disease
Nordberg, A., Rinne, J. O., Kadir, A., & Långström, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.217 · Cited by 449 · cited 1×
“The future success of disease-modifying therapies will depend on accurate early diagnosis before the onset of clinical symptoms [2,3,4].”
BackgroundHippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease
Mueller, S. G., Schuff, N., Yaffe, K., Madison, C., Miller, B., & Weiner, M. W. (2010) · Human Brain Mapping · doi:10.1002/hbm.20934 · Cited by 361 · cited 2×
“This tool has been used in many neuroimaging studies, including those focused on AD [29,30,31].”
MethodRobb, R. A., Hanson, D. P., Karwoski, R. A., Larson, A. G., Workman, E. L., & Stacy, M. C. (1989) · Computerized Medical Imaging and Graphics · doi:10.1016/0895-6111(89)90285-1 · Cited by 315 · cited 1×
“1) were manually defined according to previously described rules [11] using ANALYZE software [38] and MRI images previously transformed (12-parameter affine) to atlas space [39].”
MethodPET amyloid ligand [ 11 C]PIB uptake is increased in mild cognitive impairment
Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., Viitanen, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000260969.94695.56 · Cited by 308 · cited 1×
“Individuals with AD and mild cognitive impairment have been shown to have elevated PiB retention in the cerebral cortex [7,8,9] although elevated PiB retention is also observed in some cognitively normal individuals.”
BackgroundA Registration and Interpolation Procedure for Subvoxel Matching of Serially Acquired MR Images
Hajnal, J. V., Saeed, N., Soar, E. J., Oatridge, A., Young, I. R., & Bydder, G. M. (1995) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199503000-00022 · Cited by 304 · cited 1×
“Inter-frame motion correction for the dynamic PET images was performed using standard image registration techniques [41] implemented in in-house software [39].”
MethodLi, Y., Rinne, J. O., Mosconi, L., Pirraglia, E., Rusinek, H., DeSanti, S., Kemppainen, N., Någren, K., Kim, B.-C., Tsui, W., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0833-y · Cited by 278 · cited 1×
“many amyloid imaging studies using either hand drawn regions [11,13,14,15,17,19] or automatic templates [22,23,24], the rationale for ROI selection typically has been based on which regions have been previously reported as selectively affected by AD [11,16,24].”
BackgroundBerg, L. (1984) · British Journal of Psychiatry · doi:10.1192/s0007125000118082 · Cited by 273
Comparative evaluation of MR-based partial-volume correction schemes for PET.
MELTZER, C. C., Kinahan, P. E., Greer, P. J., Nichols, T. E., Comtat, C., Cantwell, M. N., Lin, M., & Price, J. C. (1999) · PubMed · Cited by 254
Roe, C. M., Mintun, M. A., D’Angelo, G., Xiong, C., Grant, E. A., & Morris, J. C. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1467 · Cited by 215 · cited 2×
“Binding potentials (BPND) are calculated using Logan graphical analysis [12] with cerebellar cortex as the reference region [4,11,13].”
BackgroundMethodSelf-citationComparison of 18F-FDG and PiB PET in Cognitive Impairment
Lowe, V. J., Kemp, B. J., Jack, C. R., Senjem, M., Weigand, S., Shiung, M., Smith, G., Knopman, D., Boeve, B., Mullan, B., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058529 · Cited by 192 · cited 4×
“The two-component partial volume correction technique adopted by many groups [17,22] compensates for the brain atrophy without modeling difference between gray vs.”
BackgroundMethodInfluentialMeltzer, C. C., Zubieta, J. K., Brandt, J., Tune, L. E., Mayberg, H. S., & Frost, J. J. (1996) · Neurology · doi:10.1212/wnl.47.2.454 · Cited by 182 · cited 1×
“Partial volume correction In addition to analysis based on raw regional time-activity curves, partial volume corrected results were also obtained for G1 using a two-component technique [43] that has been widely applied in the context of PiB data analysis [14,16,17].”
MethodMessina, D., Cerasa, A., Condino, F., Arabia, G., Novellino, F., Nicoletti, G., Salsone, M., Morelli, M., Lanza, P. L., & Quattrone, A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.12.010 · Cited by 163 · cited 1×
“This tool has been used in many neuroimaging studies, including those focused on AD [29,30,31].”
MethodRegistration of [18F]FDG microPET and small-animal MRI
Rowland, D. J., Garbow, J. R., Laforest, R. A., & Snyder, A. Z. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.05.002 · Cited by 109 · cited 1×
“PET-MR registration was performed using the VGM algorithm [40].”
MethodSelf-citationRelationship of dementia screening tests with biomarkers of Alzheimer's disease
Galvin, J. E., Fagan, A. M., Holtzman, D. M., Mintun, M. A., & Morris, J. C. (2010) · Brain · doi:10.1093/brain/awq204 · Cited by 107 · cited 2×
“18 as the criterion for PiB status determination [11,44,45].”
BackgroundMethodSelf-citationLehmann, M., Rohrer, J. D., Clarkson, M. J., Ridgway, G. R., Scahill, R. I., Modat, M., Warren, J. D., Ourselin, S., Barnes, J., Rossor, M. N., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1401 · Cited by 103 · cited 2×
“This tool has been used in many neuroimaging studies, including those focused on AD [29,30,31].”
MethodGrimmer, T., Tholen, S., Yousefi, B. H., Alexopoulos, P., Förschler, A., Förstl, H., Henriksen, G., Klunk, W. E., Mathis, C. A., Perneczky, R., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.013 · Cited by 101 · cited 1×
“Other regions have generally been overlooked except in voxel-based analysis [21,25].”
Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET
Rosario, B. L., Weissfeld, L. A., Laymon, C. M., Mathis, C. A., Klunk, W. E., Berginc, M. D., James, J. A., Hoge, J. A., & Price, J. C. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.12.070 · Cited by 52
Characterization of extrastriatal D2 in vivo specific binding of [18F](N‐methyl)benperidol using PET
Eisenstein, S. A., Koller, J. M., Piccirillo, M., Kim, A., Antenor‐Dorsey, J. A. V., Videen, T. O., Snyder, A. Z., Karimi, M., Moerlein, S. M., Black, K. J., et al. (2012) · Synapse · doi:10.1002/syn.21566 · Cited by 44
Self-citationVoxel-Based Analysis of 11C-PIB Scans for Diagnosing Alzheimer's Disease
Mikhno, A., Devanand, D. P., Pelton, G. H., Cuasay, K., Gunn, R. N., Upton, N., Lai, R. Y. K., Libri, V., Mann, J. J., & Parsey, R. V. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049932 · Cited by 43
Edison, P., Brooks, D. J., Turkheimer, F., Archer, H. A., & Hinz, R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.079 · Cited by 30 · cited 1×
“Additional technical variations include, but are not limited to, the use of standard uptake value ratio [17,18,19] and voxel-wise analyses [20,21].”
BackgroundAutomated 11C-PiB Standardized Uptake Value Ratio
Raniga, P., Bourgeat, P., Fripp, J., Acosta, O., Villemagne, V. L., Rowe, C. C., Masters, C. L., Jones, G. R., O'Keefe, G. J., Salvado, O., et al. (2008) · Academic Radiology · doi:10.1016/j.acra.2008.07.006 · Cited by 28 · cited 1×
“Additional technical variations include, but are not limited to, the use of standard uptake value ratio [17,18,19] and voxel-wise analyses [20,21].”
BackgroundCurrent means for identifying the latent stage of a neurodegenerative process
Illarioshkin, S. N., Vlassenko, A. G., & Fedotova, E. Y. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.17816/psaic236 · Cited by 10
Self-citationSimplified quantification of PIB amyloid imaging PET studies
Lopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., MELTZER, C. C., DeKosky, S. T., & Price, J. C. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9591524.0589 · Cited by 5
Cited by
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728
Self-citationHigh-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Schindler, S. E., Bollinger, J. G., Ovod, V., Mawuenyega, K. G., Li, Y., Gordon, B. A., Holtzman, D. M., Morris, J. C., Benzinger, T. L. S., Xiong, C., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008081 · Cited by 885
“net/) to derive cortical and subcortical regions of interest.(22) Regional data from the 40- to 60-minutes postinjection window for PiB and the 50- to 70-minutes window for AV45 were converted to standardized uptake value ratios (SUVRs) using cerebellar gray as a reference and partial volume-corrected using a regional…”
MethodSelf-citationLaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., et al. (2019) · medRxiv · doi:10.1101/2019.12.13.19014902 · Cited by 779
“PET imaging analyses were performed using the PET unified pipeline 42,43 (PUP, https://github.com/ysu001/PUP) via XNAT on Dell PowerEdge 1950 servers with Intel Xeon processors running CentOS 5.5 Linux.”
InfluentialSelf-citationTau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734
Self-citationGordon, B. A., Blazey, T. M., Su, Y., Hari-Raj, A., Dincer, A., Flores, S., Christensen, J., McDade, E., Wang, G., Xiong, C., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30028-0 · Cited by 602
Self-citation
Metadata
- Authors
- Su, Y., D'Angelo, G. M., Vlassenko, A. G., Zhou, G., Snyder, A. Z., Marcus, D. S., Blazey, T. M., Christensen, J. J., Vora, S., Morris, J. C., Mintun, M. A., & Benzinger, T. L. S.
- Affiliations
- Washington University in St. Louis (US)
- Avid Radiopharmaceuticals (United States) (US)
- Corresponding author
- Su, Yi
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-06
- Volume
- 8
- Issue
- 11
- Pages
- e73377
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3819320
- OpenAlex
- W2026331106
- Semantic Scholar
- e3e133682a673b9e141c77c635766caa40b96e5e
- Cited by
- 246
- References
- 55
- Citations by year
- 2026: 19 · 2025: 18 · 2024: 22 · 2023: 28 · 2022: 33 · 2021: 19 · 2020: 20 · 2019: 17 · 2018: 26 · 2017: 12 · 2016: 15 · 2015: 12 · 2014: 4
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute on Aging (UF1AG032438, P50AG005681, P01 AG0 3991, P01AG003991, U19AG032438, P01AG026276)
- National Institute of Mental Health (P20MH07796)
- National Institute of Neurological Disorders and Stroke (P30NS048056, P50NS006833)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Medical Image Segmentation Techniques
- Keywords
- PiB PET, amyloid PET quantification, FreeSurfer, automated brain segmentation, Alzheimer's disease, amyloid deposition, test-retest reliability
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Aniline Compounds, Brain, Female, Humans, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Software, Thiazoles, Case-Control Studies, Radiopharmaceuticals, Positron-Emission Tomography, Benzothiazoles, Plaque, Amyloid, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.